Carregant...
Targeting α-Synuclein for PD Therapeutics: A Pursuit on All Fronts
Parkinson’s Disease (PD) is characterized both by the loss of dopaminergic neurons in the substantia nigra and the presence of cytoplasmic inclusions called Lewy Bodies. These Lewy Bodies contain the aggregated α-synuclein (α-syn) protein, which has been shown to be able to propagate from cell to ce...
Guardat en:
| Publicat a: | Biomolecules |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7175302/ https://ncbi.nlm.nih.gov/pubmed/32138193 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biom10030391 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|